Amanda Marinoff
Assistant Professor
Pediatrics
School of Medicine

I am a pediatric oncologist and clinician-scientist with interests in developmental therapeutics, clinical trials, and translational genomics. My clinical and translational research focuses on advancing precision oncology in osteosarcoma.

Awards

Show all (1) Hide

• Advancing Precision Oncology in Osteosarcoma, NCI K12, 2024-2026

Education & Training

Show all (4) Hide

• Fellowship Pediatric Hematology/Oncology University of California San Francisco 2023
• Residency Pediatrics Boston Children's Hospital and Boston Medical Center 2020
• MD Medicine Harvard Medical School 2017
• BA Dartmouth College

Publications (8)

Top publication keywords:
Receptors, ThrombopoietinReceptors, FcPlatelet CountHydrazinesThrombopoietinHematologic NeoplasmsThrombocytopeniaBone NeoplasmsBone DevelopmentOsteosarcomaPyrazolesBenzoatesRecombinant Fusion ProteinsLeukemia, Myeloid, AcuteEpendymoma

• Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies.
  Pediatric blood & cancer 2025 Marinoff AE, Thrall A, Aaronson K, Braun BS, Castellanos M, Chu J, Hermiston M, Huang BJ, Levinson A, Southworth E, Winger BA, Olshen A, Stieglitz E
• Osteosarcoma through the Lens of Bone Development, Signaling, and Microenvironment.
  Cold Spring Harbor perspectives in medicine 2024 Young EP, Marinoff AE, Lopez-Fuentes E, Sweet-Cordero EA
• Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients.
  Cancer reports (Hoboken, N.J.) 2023 Shumock SS, Temple WC, Marinoff A, Aaronson K, Southworth E, Xirenayi S, Lee AG, Leung SG, Sweet-Cordero EA, Hermiston M, Higham C, Stieglitz E
• Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patient.
  Pediatric blood & cancer 2023 Meyer LK, Huang I, Huang BJ, Chung JH, Pawar A, Hermiston ML, Loh ML, Ohgami RS, Ruiz-Cordero R, Bhargava P, Marinoff AE
• Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.
  Pediatric blood & cancer 2023 Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, Michlitsch J, Southworth E, Thrall A, Vo KT, Stieglitz E
• Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.
  JCO precision oncology 2023 Marinoff AE, Spurr LF, Fong C, Li YY, Forrest SJ, Ward A, Doan D, Corson L, Mauguen A, Pinto N, Maese L, Colace S, Macy ME, Kim A, Sabnis AJ, Applebaum MA, Laetsch TW, Glade-Bender J, Weiser DA, …
• Cytomorphologic features of pediatric-type follicular lymphoma on fine needle aspiration biopsy: case series and a review of the literature.
  Journal of the American Society of Cytopathology 2022 Lu KL, Menke JR, Ng D, Ruiz-Cordero R, Marinoff A, Stieglitz E, Gollapudi S, Singh K, Ohgami RS, Vohra P
• Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
  Journal of neuro-oncology 2017 Marinoff AE, Ma C, Guo D, Snuderl M, Wright KD, Manley PE, Al-Sayegh H, Sinai CE, Ullrich NJ, Marcus K, Haas-Kogan D, Goumnerova L, London WB, Kieran MW, Chi SN, Fangusaro J, Bandopadhayay P